Zhejiang Hisun Pharmaceutical Co., Ltd.
600267.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.09B
Close$
Share Statistics
| Market cap | $14.09 Billion |
|---|---|
| Enterprise Value | $14.97 Billion |
| Dividend Yield | $0.21 (1.76%) |
| Earnings per Share | $0.46 |
| Beta | 0.29 |
| Outstanding Shares | 1,158,390,296 |
Return
| Return on Equity | 9.77% |
|---|---|
| Return on Assets | 6.46% |
| Return on Invested Capital | 11.57% |
Valuation & Multiples
| P/E Ratio | 15.75 |
|---|---|
| PEG | 9.39 |
| Price to Sales | 1.49 |
| Price to Book Ratio | 1.49 |
| Enterprise Value to Revenue | 1.53 |
| Enterprise Value to EBIT | 13.63 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.19
Average shareholder expectationRevenue Estimate
$2.09 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$2.07 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Hisun Pharmaceutical Co., Ltd.
8,751 employees
CEO: Weihong Xiao Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (AP...